Journal profile · IMMUNOLOGY-INFECTIOUS DISEASES
Current Opinion in HIV and AIDS
ISSN 1746-630X · eISSN 1746-6318 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Founded 2006
Current Opinion in HIV and AIDS: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.47; JCR Q2 (journal website); hybrid open access; review 6–12 weeks (community reports); 93 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Opinion in HIV and AIDS is published by Lippincott Williams and Wilkins Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, HIV/AIDS Research and Interventions and HIV/AIDS drug development and treatment, together about 53.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Published bimonthly and offering a unique and wide ranging perspective on the key developments in the field, each issue of Current Opinion in HIV and AIDS features hand-picked review articles from our team of expert editors. With six disciplines published across the year – including HIV and ageing, a HIV vaccine, and epidemiology – every issue also contains annotated reference detailing the merits of the most important papers.
Source: LetPub
Research area (LetPub): IMMUNOLOGY-INFECTIOUS DISEASES
Editor-in-chief Steven G DeeksPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV Research and TreatmentImmunology and Microbiology22.7%
- HIV/AIDS Research and InterventionsMedicine17.2%
- HIV/AIDS drug development and treatmentMedicine13.2%
- HIV-related health complications and treatmentsMedicine11.1%
- Biological Research and Disease StudiesBiochemistry, Genetics and Molecular Biology3.2%
- HIV, Drug Use, Sexual RiskMedicine3%
- Adolescent Sexual and Reproductive HealthHealth Professions2.8%
- HIV/AIDS Impact and ResponsesEconomics, Econometrics and Finance2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · IMMUNOLOGY · rank 93/183
- JCR Q2 · INFECTIOUS DISEASES · rank 49/141
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.47LetPub ·
- Impact factor (publisher)
- 3.4Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 1.33LetPub ·
- SNIP 2026-06
- 1.1LetPub ·
- h-index
- 53LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 968OpenAlex ·
- 2-year mean citedness
- 3.53OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 24.28%LetPub ·
Volume
- Articles per year
- 80LetPub ·
Articles by year OpenAlex count · 1,661 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 19 | 11 |
| 2025 | 93 | 48 | 302 |
| 2024 | 65 | 35 | 436 |
| 2023 | 51 | 28 | 470 |
| 2022 | 60 | 30 | 943 |
| 2021 | 42 | 15 | 876 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2006
- ISSN
- 1746-630X
- Electronic ISSN
- 1746-6318
- Latest issue on the website
- Volume 21, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Opinion in HIV and AIDS
What CAS zone is Current Opinion in HIV and AIDS in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Opinion in HIV and AIDS is in Zone 2 of Medicine, and in Zone 2 of the minor category Immunology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Opinion in HIV and AIDS?
The latest impact factor listed by LetPub is 3.47; CiteScore 5.8, h-index 100.
How long does peer review take at Current Opinion in HIV and AIDS?
Authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Current Opinion in HIV and AIDS in?
The journal's website gives JCR Q2; by category, IMMUNOLOGY Q3 (93/183), INFECTIOUS DISEASES Q2 (49/141). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Which databases index Current Opinion in HIV and AIDS?
According to LetPub and DOAJ records, Current Opinion in HIV and AIDS is indexed in SCIE and Scopus.
Is Current Opinion in HIV and AIDS open access, and what is the APC?
Current Opinion in HIV and AIDS is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .